Published pharmacoeconomic analyses: science or marketing?

被引：4
|
作者：
Henry, D [1 ]
Lang, D [1 ]
机构：
[1] Univ Newcastle, Sch Med Practice & Populat Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2003年 / 33卷 / 9-10期
关键词：
D O I：
10.1046/j.1445-5994.2003.00473.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：403 / 404
页数：2
相关论文
共 50 条
  • [41] The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
    Hiligsmann, Mickael
    Boonen, Annelies
    Rabenda, Veronique
    Reginster, Jean-Yves
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (02) : 159 - 166
  • [42] Adapting Pharmacoeconomic Data and Methods to Extend the Postpublication Utility of Analyses
    Lyles, Alan
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 192 - 193
  • [43] THE DANGERS OF GENERALIZING FROM PUBLISHED MARKETING STUDIES
    HUBBARD, R
    JOURNAL OF THE MARKET RESEARCH SOCIETY, 1994, 36 (03): : 257 - 260
  • [44] HOW TO GET PUBLISHED IN THE BEST MARKETING JOURNALS
    Roy, Abhijit
    JOURNAL OF INTERNATIONAL CONSUMER MARKETING, 2020, 32 (04) : 352 - 354
  • [45] Intravenous Acetaminophen: A Review of Pharmacoeconomic Science for Perioperative Use
    Jahr, Jonathan S.
    Filocamo, Peter
    Singh, Sumit
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (02) : 189 - 199
  • [46] Pharmacoeconomic analyses - Making them transparent, making them credible
    Rennie, D
    Luft, HS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2158 - 2160
  • [47] The role of government and private insurers in guiding and implementing pharmacoeconomic analyses
    Freund, DA
    Luce, BR
    PHARMACOECONOMICS, 1998, 13 (04) : 383 - 387
  • [48] Comments on three comparative analyses of stem taper models published in Journal of Mountain Science in 2014–2016
    Harold E. Burkhart
    Journal of Mountain Science, 2016, 13 : 534 - 535
  • [49] Using healthcare claims data for outcomes research and pharmacoeconomic analyses
    Birnbaum, HG
    Cremieux, PY
    Greenberg, PE
    LeLorier, J
    Ostrander, J
    Venditti, L
    PHARMACOECONOMICS, 1999, 16 (01) : 1 - 8
  • [50] The Role of Government and Private Insurers in Guiding and Implementing Pharmacoeconomic Analyses
    Deborah A. Freund
    Bryan R. Luce
    PharmacoEconomics, 1998, 13 : 383 - 387
12345